Clinical trials
Enrolling by invitation Observational Substance-Related Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tampere University Hospital | 2 |
| Evidation Health | 1 |
| Lauro Gutiérrez Castro | 1 |
| National Institute on Drug Abuse (NIDA) | 1 |
| Ottawa Hospital Research Institute | 1 |
| Senthil Sadhasivam | 1 |
| Truway Health, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Substance-Related Disorders | 8 |
| Anxiety Disorders | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Histiocytosis | 1 |
| Narcotic-Related Disorders | 1 |
| Opioid-Related Disorders | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.